CONDITION

Chronic Hepatitis in Dogs

Chronic hepatitis in dogs describes ongoing inflammation in the liver that persists over weeks to months, gradually affecting how the liver works. The liver has a remarkable capacity to compensate, which means signs often emerge slowly and can be subtle at first — things like reduced appetite, occasional vomiting, increased thirst, or a general sense that a dog is not quite themselves. In some cases, jaundice (a yellowing of the gums or skin) appears, or fluid begins to accumulate in the abdomen. Owners often arrive at this page after blood tests have shown changes in liver enzymes, or because a dog has been losing weight or seems less energetic over time. The condition can have many underlying causes — some related to the immune system, some to copper accumulation, some to infections, and in many cases the cause remains unclear even after investigation. This page explores the signs that may be observed, what is happening in the liver tissue itself, how chronic hepatitis is investigated through blood work and imaging, and the range of approaches that exist to support liver function and address underlying causes where they can be identified.

Why this matters now

Chronic hepatitis in dogs tends to be recognised in middle-aged to older animals, typically between four and ten years of age, though younger dogs can be affected. Certain breeds—including Bedlington Terriers, Dobermanns, Labrador Retrievers, Cocker Spaniels, and West Highland White Terriers—appear more frequently in clinical case series, which may reflect genetic factors influencing copper handling, immune regulation, or susceptibility to specific toxins. In many cases, the condition develops gradually without an obvious external trigger, though prolonged medication use, previous infections, or dietary copper imbalance may contribute in some individuals.

The condition often unfolds over months to years, with signs emerging slowly as the liver's compensatory capacity is gradually exceeded. Some dogs show steady, subtle decline in energy and appetite, while others experience periods of relative stability punctuated by episodes of vomiting or lethargy. The rate of progression varies widely between individuals and depends in part on the underlying cause, the degree of inflammation, and whether fibrosis—scarring of liver tissue—has begun to develop. In a proportion of cases, the disease eventually progresses to cirrhosis, a state in which normal liver architecture is replaced by scar tissue and the organ's function becomes more severely compromised.

Signals & patterns

Early signals

Reduced appetite or pickiness

A dog may begin leaving food in the bowl, eating more slowly, or showing less enthusiasm at mealtimes. This can be intermittent at first, making it easy to attribute to other factors such as stress or a change in routine.

Increased thirst and urination

The liver's role in processing waste products and maintaining fluid balance can be subtly disrupted, leading to a dog drinking more water and needing to go outside more frequently. Owners often notice the water bowl needs refilling more often or that the dog is asking to go out during the night.

Quieter than usual

A dog may seem less interested in play, slower to get up from rest, or less inclined to greet family members with the usual energy. The change can be so gradual that it is only clear in hindsight, particularly in older dogs where it may be mistaken for normal ageing.

Occasional vomiting

Episodes of vomiting may occur every few days or weeks, sometimes containing bile or undigested food. The pattern is often inconsistent, which can make it difficult to identify a clear cause without further investigation.

Weight loss despite normal eating

Some dogs continue to eat reasonably well but lose weight gradually over weeks to months. This reflects the liver's reduced ability to process nutrients and maintain normal metabolism, even when food intake appears adequate.

Later signals

Jaundice

A yellowing of the gums, the whites of the eyes, or the skin becomes visible when the liver can no longer process bilirubin efficiently. This tends to appear as the disease progresses and liver function becomes more significantly impaired.

Abdominal swelling

Fluid may begin to accumulate in the abdomen, a condition called ascites, which makes the belly appear distended or rounded. This reflects both changes in blood flow through the liver and reduced production of proteins that help keep fluid in the bloodstream.

Neurological changes

In some cases, dogs develop subtle behavioural changes such as disorientation, staring into space, or episodes of apparent confusion. These signs, sometimes grouped under the term hepatic encephalopathy, occur when the liver can no longer filter toxins from the blood effectively, allowing them to affect the brain.

Bleeding or bruising tendency

The liver produces many of the proteins involved in blood clotting, so as function declines, a dog may bleed more easily from minor injuries or show bruising under the skin. Owners may notice blood in the urine, stool, or prolonged bleeding from a small cut.

Click to read about the biological mechanisms

How this is usually investigated

Investigation of chronic hepatitis typically begins with a review of the dog's history—including breed, age, medications, and the pattern of signs over time—followed by physical examination to check for jaundice, abdominal fluid, or changes in liver size. Blood tests are usually the next step, looking at liver enzymes, markers of liver function, and other organ systems. As the picture develops, imaging and sometimes tissue sampling help clarify the extent of damage and, in some cases, point toward an underlying cause.

Blood biochemistry and haematology

Purpose: These tests measure liver enzymes such as ALT and ALP, which can indicate ongoing liver cell damage, as well as markers of liver function including albumin, bilirubin, bile acids, and clotting factors. They also assess other organ systems and can reveal anaemia or changes in white blood cells.
Considerations: Elevated liver enzymes indicate damage but do not distinguish between different causes or reveal how much functional liver tissue remains. Normal enzyme levels do not rule out significant liver disease if damage has been long-standing and enzyme release has slowed.

Abdominal ultrasound

Purpose: Ultrasound allows the liver's size, shape, and internal texture to be visualised, and can detect fluid in the abdomen, changes in blood vessels, or masses. It also examines nearby structures such as the gallbladder and spleen.
Considerations: Ultrasound cannot identify the specific type of inflammation or scarring present, and a liver that appears relatively normal on imaging can still harbour significant microscopic disease. It is observer-dependent and findings are often described in general terms.

Liver biopsy and histopathology

Purpose: A small sample of liver tissue, obtained by needle or during surgery, is examined under the microscope to assess the type and severity of inflammation, the degree of fibrosis, and the presence of abnormal substances such as copper. This can help distinguish between immune-mediated disease, toxic injury, and other patterns.
Considerations: Biopsy carries a small risk of bleeding, particularly in dogs with impaired clotting, and requires sedation or anaesthesia. The sample represents only a small portion of the liver, and disease distribution can be patchy, meaning some cases may be underestimated.

Copper quantification

Purpose: Measurement of copper concentration in liver tissue can identify dogs in which copper accumulation is contributing to inflammation and damage, particularly in breeds with known genetic susceptibility.
Considerations: Elevated copper can be a cause of hepatitis or a consequence of cholestasis—impaired bile flow—so interpretation depends on the broader histological picture. Not all laboratories routinely quantify copper unless specifically requested.

Serology and infectious disease testing

Purpose: Blood tests for specific infectious agents, such as leptospirosis or certain tick-borne diseases, can identify infections that may trigger or contribute to chronic liver inflammation.
Considerations: Many chronic hepatitis cases show no evidence of active infection, and past exposure does not always indicate ongoing disease. Testing is typically guided by travel history, exposure risk, and clinical signs beyond the liver.

Options & trade-offs

Management of chronic hepatitis is usually built from several components, tailored to the individual dog's histology, bloodwork findings, and practical circumstances. The aim is to slow progression of inflammation and fibrosis, support liver function, and address underlying causes where they can be identified. Different combinations suit different households, depending on the dog's tolerance of medication, the ease of monitoring, and the degree of liver compromise present.

Immunosuppressive therapy

Drugs such as prednisolone or azathioprine are used to dampen the immune response when inflammation appears to be immune-mediated or when no other cause has been found. The dose is typically adjusted over time based on clinical response and blood test trends. Treatment may continue for months or years, and in some cases is withdrawn gradually if remission is sustained.

Trade-offs: Immunosuppressive drugs can increase susceptibility to infection, cause side effects such as increased thirst and appetite, and require regular monitoring of blood counts and liver function. They may not be effective in cases driven primarily by toxins or structural damage, and response varies between individuals.

Copper chelation and dietary restriction

Chelating agents such as d-penicillamine bind copper in the liver and promote its excretion, while diets low in copper reduce further accumulation. This approach is particularly relevant in breeds prone to copper storage disease and in dogs with documented copper elevation on biopsy.

Trade-offs: Chelation therapy can take many months to reduce liver copper levels, and some dogs experience gastrointestinal upset or other side effects. Dietary restriction alone is usually insufficient if copper levels are already high, and compliance depends on the availability of suitable foods and the dog's willingness to eat them.

Antioxidants and hepatoprotective agents

Compounds such as ursodeoxycholic acid, S-adenosylmethionine, and vitamin E are used with the intention of reducing oxidative stress, supporting bile flow, and protecting hepatocytes from further injury. These are often given alongside other treatments rather than as sole therapy.

Trade-offs: Evidence for clinical benefit is variable, and these agents are unlikely to reverse established fibrosis or address active inflammation on their own. They are generally well tolerated, though cost and the need for long-term administration can be considerations for some owners.

Dietary modification

Diets formulated to be highly digestible, moderate in high-quality protein, and enriched with certain antioxidants and vitamins are sometimes used to reduce the metabolic burden on the liver and support nutritional status. In dogs with ascites or signs of hepatic encephalopathy, protein sources and sodium content may be adjusted.

Trade-offs: Dietary change alone does not address the underlying inflammation, and some dogs find prescription diets less palatable or develop looser stools during transition. The benefit is often modest and difficult to separate from other concurrent treatments.

Monitoring and supportive care

Regular blood tests, clinical assessment, and adjustment of other treatments as the disease evolves form the backbone of management in many cases. Symptomatic support—such as anti-nausea medication, appetite stimulants, or fluid therapy during flare-ups—can improve quality of life even when disease-modifying treatment is limited.

Trade-offs: Monitoring requires repeated visits and blood sampling, which can be stressful for some dogs and adds to the overall cost of management. It provides information on trend rather than immediate guidance, and abnormalities may persist despite clinical improvement.

Common misconceptions

Misconception:

"A dog with chronic hepatitis will always develop liver failure."

Reality:

Many dogs with chronic hepatitis live for years with stable or slowly progressive disease, particularly when inflammation is controlled and fibrosis remains limited. The trajectory varies widely, and some individuals respond well to treatment with minimal impact on lifespan or quality of life.

Misconception:

"Liver enzyme levels tell you how much liver function remains."

Reality:

Liver enzymes such as ALT and ALP indicate active cell damage or bile flow disruption, but they do not measure the liver's capacity to perform its functions. A dog can have high enzymes yet retain good function, or conversely, have normal or falling enzymes because most functional tissue has already been lost.

Misconception:

"Once the cause of hepatitis is identified, the disease can be cured."

Reality:

Even when an underlying cause such as copper accumulation or immune-mediated inflammation is recognised, treatment usually aims to slow progression and manage symptoms rather than reverse established changes. Fibrosis and architectural distortion, once present, tend to persist, and long-term management is the norm in most cases.

Related conditions

Copper-Associated Hepatopathy

Copper-associated hepatopathy is one of the recognised underlying causes of chronic hepatitis in dogs, particularly in breeds predisposed to copper accumulation. When copper builds up to toxic levels in the liver, it can trigger the ongoing inflammation that defines chronic hepatitis.

Cirrhosis in Dogs

Cirrhosis can develop as an end-stage consequence of chronic hepatitis, when prolonged inflammation leads to widespread scarring and loss of functional liver tissue. Not all dogs with chronic hepatitis progress to cirrhosis, but it represents the pattern that can emerge if the underlying inflammation continues over years.

Hepatic Encephalopathy

Hepatic encephalopathy may occur in dogs with advanced chronic hepatitis when the liver's capacity to filter toxins from the bloodstream becomes significantly impaired. The neurological signs reflect the degree to which liver function has declined, rather than a separate disease process.

Acute Hepatic Failure

Acute hepatic failure describes a sudden loss of liver function, in contrast to the slow, progressive nature of chronic hepatitis. In some cases, a dog with underlying chronic hepatitis may experience an acute deterioration, though the two patterns usually represent different trajectories of liver disease.

Gallbladder Mucocele

Gallbladder mucocele can occasionally co-occur with chronic hepatitis, and both conditions may share underlying metabolic or inflammatory factors. When they appear together, distinguishing the contribution of each to a dog's clinical signs can require careful investigation.

Chronic hepatitis sits within a broader landscape of metabolic health, and understanding how the liver interacts with nutrition, immune regulation, and toxin handling can inform day-to-day decisions. Other conditions affecting the liver—such as portosystemic shunts, acute hepatitis, or biliary disease—may share some features but differ in their course and management. If bloodwork or imaging has raised questions, this may be a useful starting point for conversations during routine appointments or when planning longer-term monitoring.